Daniele Lisboa Ribeiro

Daniele Lisboa Ribeiro

Auto-generated profile, based on publicly available information

Daniele Lisboa Ribeiro

Department of Cell Biology, Histology and Embryology, Institute of Biomedical Sciences, Federal University of Uberlândia (UFU), Uberlândia 38405-318, MG, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2023 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
LGLaura Calazans de Melo Gomes
Laura Calazans de Melo Gomes
ACAmanda Branquinho de Oliveira Cunha
Amanda Branquinho de Oliveira Cunha
LPLuiz Felipe Fernandes Peixoto
Luiz Felipe Fernandes Peixoto
RZRenata Graciele Zanon
Renata Graciele Zanon
FBFrançoise Vasconcelos Botelho
Françoise Vasconcelos Botelho
DRDaniele Lisboa Ribeiro
Daniele Lisboa Ribeiro

9 January 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GTGuilherme Henrique Tamarindo
Guilherme Henrique Tamarindo
DRDaniele L. Ribeiro
Daniele L. Ribeiro
MGMarina G. Gobbo
Marina G. Gobbo
LGLuiz H. A. Guerra
Luiz H. A. Guerra
PRPaula Rahal
Paula Rahal
RGRejane Maira Góes
Rejane Maira Góes
Prostate cancer development has been associated with changes in mitochondrial activity and reactive oxygen species (ROS) production. Melatonin (MLT) and docosahexaenoic acid (DHA) have properties to modulate both, but their protective role, mainly at early stages of prostate cancer, remains unclear. In this study, the effects of MLT and DHA, combined or not, on PNT1A cells with regard to mitochondria bioenergetics, ROS production, and proliferation-related pathways were examined. Based on dose response and lipid accumulation assays, DHA at 100 μM and MLT at 1 μM for 48 h were chosen. DHA doubled and MLT reduced (40%) superoxide anion production, but coincubation (DM) did not normalize to control. Hydrogen peroxide production decreased after MLT incubation only (p<0.01). These alterations affected the area and perimeter of mitochondria, since DHA increased whereas MLT decreased, but such hormone has no effect on coincubation. DHA isolated did not change the oxidative phosphorylation rate (OXPHOS), but decreased (p<0.001) the mitochondrial bioenergetic reserve capacity (MBRC) which is closely related to cell responsiveness to stress conditions. MLT, regardless of DHA, ameliorated OXPHOS and recovered MBRC after coincubation. All incubations decreased AKT phosphorylation; however, only MLT alone inhibited p-mTOR. MLT increased p-ERK1/2 and, when combined to DHA, increased GSTP1 expression (p<0.01). DHA did not change the testosterone levels in the medium, whereas MLT alone or coincubated decreased by about 20%; however, any incubation affected AR expression. Moreover, incubation with luzindole revealed that MLT effects were MTR1/2-independent. In conclusion, DHA increased ROS production and impaired mitochondrial function which was probably related to AKT inactivation; MLT improved OXPHOS and decreased ROS which was related to AKT/mTOR dephosphorylation, and when coincubated, the antiproliferative action was related to mitochondrial bioenergetic modulation associated to AKT and ERK1/2 regulation. Together, these findings point to the potential application of DHA and MLT towards the prevention of proliferative prostate diseases.

10 April 2018 in The Prostate
Verified
Journal Article
Closed access
PDF file
BLBreno C. Landim
Breno C. Landim
MJMariana M. de Jesus
Mariana M. de Jesus
BBBeatriz P. Bosque
Beatriz P. Bosque
RZRenata G. Zanon
Renata G. Zanon
CSClaudio V. da Silva
Claudio V. da Silva
DRDaniele L. Ribeiro
Daniele L. Ribeiro

1 January 2022 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
FMFrancyelle B.R. DE Moura
Francyelle B.R. DE Moura
BFBruno Antonio Ferreira
Bruno Antonio Ferreira
EMElusca Helena Muniz
Elusca Helena Muniz
RSRinara A. Santos
Rinara A. Santos
JGJosé Augusto L. Gomide
José Augusto L. Gomide
TTTatiana Carla Tomiosso
Tatiana Carla Tomiosso
Wounds treated with TiO2 nanoparticles (TiO2-NPs) show an improvement in healing time. However, little is known about the parameters that can contribute to this result. On the other hand, the treatment of wounds with polyphenols is widely known. These compounds are found in the peel of Annona crassiflora fruit and have antioxidant, analgesic and anti-inflammatory properties. In this study, we evaluated the healing effect of TiO2 nanocrystals (TiO2-NCs), polyphenolic fractions obtained from ethanolic extract of A. crassiflora fruit peel (PFAC) and mix (PFAC + TiO2-NCs) on the parameters of wound closure, inflammation, collagen deposition, metalloproteinase activity (MMPs) and angiogenesis. TiO2-NCs and PFAC have activity for wound healing, showed anti-inflammatory action and a shorter wound closure time. These treatments also contributed to increased collagen deposition, while only treatment with TiO2-NCs increased MMP-2 activity, parameters essential for the migration of keratinocytes and for complete restoration of the injured tissue. The combination of PFAC + TiO2-NCs reduced the effectiveness of individual treatments by intensifying the inflammatory process, in addition to delaying wound closure. We conclude that the interaction between the hydroxyl groups of PFAC polyphenols with TiO2-NCs may have contributed to difference in the healing activity of skin wounds.

13 March 2021 in Advances in Research
Verified
Journal Article
Closed access
PDF file
JBJeranice Silva Barbosa
Jeranice Silva Barbosa
FMFrancyelle Borges Rosa de Moura
Francyelle Borges Rosa de Moura
BFBruno Antonio Ferreira
Bruno Antonio Ferreira
FMFlávia Alves Martins
Flávia Alves Martins
EMElusca Helena Muniz
Elusca Helena Muniz
TTTatiana Carla Tomiosso
Tatiana Carla Tomiosso
Aims: Recombinant proteins rP2 has demonstrated biological activity in inflammation by acting on the recruitment of leukocytes and by inducing phagocytosis, also modulating the processes of angiogenesis and fibrogenesis in different experimental models. In this study we evaluated the effects of the recombinant protein rP21 from Trypanosama cruzi in cutaneous wounds. Study Design: The wounds were induced on the back of mice and treated with rP21 at 1 µg/mL and 50 µg/mL concentration, for 3 and 7 days. Study Location and Duration: Institute of Biomedical Sciences and Animal Breeding Network and Rodents of the Federal University of Uberlândia, between February 2015 and February 2016. Methodology: The contraction time of wound, inflammatory cell activities (neutrophils and macrophages), angiogenesis and local collagen density were evaluated. Sample: Wound induction was performed on 64 male BALB / c mice approximately 9 weeks old. Results: Wounds treated with rP21 showed less closure time, in addition to exhibiting greater neutrophil activity in the initial phasis, which was reduced simultaneously with the increased macrophage activity. The rP21 also performed pro-angiogenic and pro-fibrogenic activity in this study model. Conclusion: These results demonstrate for the first time the biological potential of rP21 in accelerating skin tissue repair.

Verified
Journal Article
Open access
PDF file
HPHelen F. M. Pacheco
Helen F. M. Pacheco
JFJhessyka L. F. Fernandes
Jhessyka L. F. Fernandes
FDFernanda Dias
Fernanda Dias
MDMarina C. Deus
Marina C. Deus
DRDaniele L. Ribeiro
Daniele L. Ribeiro
MGMarcos Lucca Moreira Gomes
Marcos Lucca Moreira Gomes
(1) The primary prostate cancer treatment involves androgen deprivation therapy, with or without chemotherapy. Immunotherapy has emerged as a promising strategy against cancer due to its ability to modulate the immune system, overcome immune evasion, and stimulate the attack on tumor cells. Thus, this review urges an exploration of the underlying mechanisms to validate the efficacy and safety of dendritic cell immunotherapy for prostate cancer treatment. (2) An extensive literature search identified 45 eligible studies in PubMed, Web of Science, SCOPUS, and Embase databases. Phase I and II clinical trials and in vitro studies (PROSPERO registration number CRD42024538296) were analyzed to extract information on patient selection, vaccine preparation, treatment details, and disease progression. (3) Despite significant variability in vaccine development and treatment protocols, vaccines were shown to induce satisfactory immune responses, including T-cell activation, increased CD4 and CD8 cell populations, upregulated expression of HLA-A2 and HLA-DR, enhanced migratory capacity of dendritic cells, and elevated interferon levels. Cytokine responses, particularly involving Interleukin 10 (IL-10) and Interleukin 12 (IL-12), varied across studies. Immunotherapy demonstrated potential by eliciting positive immune responses, reducing PSA levels, and showing an acceptable safety profile. However, side effects such as erythema and fever were observed. (4) The analyzed treatments were well-tolerated, but variability in clinical responses and side effects underscores the need for further research to optimize the efficacy and safety of this therapeutic approach.